3 US Penny Stocks With Market Caps Up To 400M
| NAUT Stock | USD 1.71 0.01 0.58% |
Slightly above 61% of Nautilus Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Nautilus Biotechnology suggests that many traders are alarmed. Nautilus Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Nautilus Biotechnology's earnings reports, geopolitical events, and overall market trends.
Nautilus |
As the U.S. stock market reaches record highs following Donald Trumps election victory, investors are keenly observing how different sectors and asset classes will perform under the new administration. Amidst this backdrop, penny stocksoften representing smaller or newer companiesremain a point of interest for those seeking unique investment opportunities. Though the term penny stock might sound like a relic of past trading days, these stocks can still offer significant growth potential...
Read at finance.yahoo.com
 |
Nautilus Biotechnology Fundamental Analysis
We analyze Nautilus Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nautilus Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nautilus Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Nautilus Biotechnology is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Nautilus Biotechnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nautilus Biotechnology stock to make a market-neutral strategy. Peer analysis of Nautilus Biotechnology could also be used in its relative valuation, which is a method of valuing Nautilus Biotechnology by comparing valuation metrics with similar companies.
Peers
Nautilus Biotechnology Related Equities
| BEAM | Beam Therapeutics | 13.25 | ||||
| MNOV | MediciNova | 5.35 | ||||
| BCAB | Bioatla | 4.55 | ||||
| DTIL | Precision BioSciences | 4.15 | ||||
| CRBU | Caribou Biosciences | 3.05 | ||||
| IPSC | Century Therapeutics | 2.67 | ||||
| KYMR | Kymera Therapeutics | 0.68 | ||||
| CSBR | Champions Oncology | 0.09 | ||||
| FHTX | Foghorn Therapeutics | 0.49 | ||||
| CCCC | C4 Therapeutics | 0.63 | ||||
| RVMD | Revolution Medicines | 1.57 | ||||
| PMVP | Pmv Pharmaceuticals | 2.11 | ||||
| HCWB | HCW Biologics | 2.44 | ||||
| MOLN | Molecular Partners | 2.44 | ||||
| RZLT | Rezolute | 4.16 | ||||
| ANEB | Anebulo Pharmaceuticals | 7.64 |
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.